← All runs · Coder view for P16
Replay LRUN-00016 criteria library
Live recomputation (nothing written): identical hash
- Stored replay hash
df3873637fe81bb6c979d8f34803e2dbea15efccc5393f5d5c426cc7ed548e9d- Recomputed replay hash
df3873637fe81bb6c979d8f34803e2dbea15efccc5393f5d5c426cc7ed548e9d- Measurement-side replay hash
43a12bb6d840ee2353691d06b7acd8022a2bed173d5e9f09400976951726b9d3- Inputs intact
- yes
- Engine and default set
- library-engine 1.0 · library_default_set@1.0
- Trigger
- seed · Fri Nov 13, 2026 04:55 PM · after kidney check RUN-00016
| Definition | File sha256 |
|---|---|
ada2026_diabetes@1.0 | e6a402d238eabf94… |
ada2026_hypoglycaemia@1.0 | 46bd77ec8ba977e0… |
ada2026_prediabetes@1.0 | af2c23fe63c64897… |
aha2018_severe_hypercholesterolaemia@1.0 | 07ac207b49ba33e7… |
atp3_ldl@1.0 | 984f30f535df92c4… |
berlin2012_ards_pf@1.0 | f6d9be0dcd8cd4f8… |
cdc_adult_bmi@1.0 | 14a2ac45496eea31… |
esc2024_office_bp@1.0 | f507c6c22d66becc… |
ese2014_hyponatraemia@1.0 | 80cb82e9b02b3fc8… |
global2024_ards_intubated_pf@1.0 | 64bbc3f7fa5c4c0c… |
gold2026_copd_airflow@1.0 | 5fe646eb07866c22… |
nhlbi_bp_categories@1.0 | 17c10323497aaed9… |
sepsis3_septic_shock_lactate@1.0 | 349d2d1b41e02f6a… |
uhf2021_hf_ef_category@1.0 | d056531cd58ff1c1… |
ukka2026_hyperkalaemia@1.0 | 52e59d35a9e19548… |
who1994_osteoporosis@1.0 | 285f666b9d1cbe75… |
who2020_iron_deficiency_ferritin@1.0 | 1cf50051fb66f445… |
who2024_anaemia@1.0 | f2ece42ed4d73490… |
who_adult_bmi@1.0 | de4e41b72636521d… |
Stored inputs (exactly what the definitions read)
{
"as_of": "2026-11-13T16:55:00-05:00",
"context": {
"has_diabetes": {
"source": "problem list (synthetic)",
"value": true
}
},
"encounter": {
"admit_dt": "2026-11-11T09:00:00-05:00",
"discharge_dt": null,
"encounter_id": "KE-P16",
"setting": "inpatient"
},
"entered": [
{
"code": "E16.2",
"description": "Hypoglycemia, unspecified",
"dx_id": "LD-P16-1",
"source": "visit diagnosis list (synthetic)"
}
],
"measurements": [
{
"analyte": "hba1c",
"flags": [],
"measurement_id": "LM-P16-01",
"ref_high": null,
"ref_low": null,
"time": "2026-04-25T09:00:00-04:00",
"unit": "%",
"value": 8.0
},
{
"analyte": "hba1c",
"flags": [],
"measurement_id": "LM-P16-02",
"ref_high": null,
"ref_low": null,
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
},
{
"analyte": "glucose_plasma",
"flags": [],
"measurement_id": "LM-P16-03",
"ref_high": null,
"ref_low": null,
"time": "2026-11-11T10:00:00-05:00",
"unit": "mg/dL",
"value": 182.0
},
{
"analyte": "glucose_plasma",
"flags": [],
"measurement_id": "LM-P16-04",
"ref_high": null,
"ref_low": null,
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
},
{
"analyte": "potassium_serum",
"flags": [],
"measurement_id": "LM-P16-05",
"ref_high": null,
"ref_low": null,
"time": "2026-11-12T07:00:00-05:00",
"unit": "mmol/L",
"value": 5.3
}
],
"note": {
"note_id": "KN-P16-1",
"reading": {
"default_status": "silent",
"families": {
"blood_pressure": {
"faults": [],
"spans": [],
"status": "silent"
},
"bmi": {
"faults": [],
"spans": [],
"status": "silent"
},
"bone_density": {
"faults": [],
"spans": [],
"status": "silent"
},
"copd_airflow": {
"faults": [],
"spans": [],
"status": "silent"
},
"diabetes": {
"faults": [],
"spans": [
{
"assertion": "affirmed",
"categories": [],
"end": 265,
"family": "diabetes",
"general": true,
"origin": "both",
"quote": "diabetes",
"start": 257,
"words": [
"type 2"
]
}
],
"status": "stated"
},
"ferritin": {
"faults": [],
"spans": [],
"status": "silent"
},
"haemoglobin": {
"faults": [],
"spans": [],
"status": "silent"
},
"heart_failure_ef": {
"faults": [],
"spans": [],
"status": "silent"
},
"hypoglycaemia": {
"faults": [],
"spans": [],
"status": "silent"
},
"lactate": {
"faults": [],
"spans": [],
"status": "silent"
},
"ldl": {
"faults": [],
"spans": [],
"status": "silent"
},
"oxygenation": {
"faults": [],
"spans": [],
"status": "silent"
},
"potassium": {
"faults": [],
"spans": [],
"status": "silent"
},
"prediabetes": {
"faults": [],
"spans": [],
"status": "silent"
},
"sodium": {
"faults": [],
"spans": [],
"status": "silent"
}
},
"lexicon": "library-lexicon 1.0",
"model_status": "ok",
"reader": "lexicon+model",
"text_sha256": "e7aea5e3f27fcd05cce65dda8bb8eebf3a6077a7df7fda6a950cd3d79f391a00"
}
},
"patient": {
"birth_date": "1952-11-16",
"patient_id": "P16",
"sex": "M"
},
"settings": {
"ctcae_grading": false
}
}Stored output
{
"coder_rows": [
{
"assessment": "no_action",
"assessment_label": "Nothing to act on",
"category": "below_threshold",
"category_label": "Below 5.5 mmol/L",
"condition": "Hyperkalaemia",
"definition": "ukka2026_hyperkalaemia@1.0",
"detail": "",
"entered": [],
"expected_codes": [],
"family": "potassium",
"note": {
"mentions": [],
"quotes": [],
"status": "silent"
},
"open": false,
"query_available": false,
"reasons": [],
"specificity_distinguished": null,
"state": "not_met",
"supported": null,
"tier": "measured",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P16-05",
"time": "2026-11-12T07:00:00-05:00",
"unit": "mmol/L",
"value": 5.3
}
]
},
{
"assessment": "supported_specific",
"assessment_label": "Supported and specific",
"category": "confirmed",
"category_label": "Diabetes criteria met: two abnormal results (different tests, or the same test at two times)",
"condition": "Diabetes mellitus",
"definition": "ada2026_diabetes@1.0",
"detail": "",
"entered": [],
"expected_codes": [],
"family": "diabetes",
"note": {
"mentions": [
{
"assertion": "affirmed",
"quote": "diabetes"
}
],
"quotes": [
"diabetes"
],
"status": "stated"
},
"open": false,
"query_available": false,
"reasons": [],
"specificity_distinguished": null,
"state": "met",
"supported": {
"category": "confirmed",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
},
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
},
{
"assessment": "no_action",
"assessment_label": "Nothing to act on",
"category": "diabetes_range",
"category_label": "A result is in the diabetes range \u2014 prediabetes not assigned; see ada2026_diabetes",
"condition": "Prediabetes",
"definition": "ada2026_prediabetes@1.0",
"detail": "",
"entered": [],
"expected_codes": [],
"family": "prediabetes",
"note": {
"mentions": [],
"quotes": [],
"status": "silent"
},
"open": false,
"query_available": false,
"reasons": [],
"specificity_distinguished": null,
"state": "not_met",
"supported": null,
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
},
{
"assessment": "less_specific",
"assessment_label": "Supported, but entered or stated less specifically than the record supports",
"category": "level_1",
"category_label": "Level 1: glucose <70 mg/dL (<3.9 mmol/L) and \u226554 mg/dL (\u22653.0 mmol/L)",
"condition": "Hypoglycaemia (in people with diabetes)",
"definition": "ada2026_hypoglycaemia@1.0",
"detail": "entered E16.2 (Hypoglycemia, unspecified)",
"entered": [
{
"code": "E16.2",
"description": "Hypoglycemia, unspecified",
"dx_id": "LD-P16-1",
"source": "visit diagnosis list (synthetic)"
}
],
"expected_codes": [
{
"code": "E16.A1",
"description": "Hypoglycemia level 1"
}
],
"family": "hypoglycaemia",
"note": {
"mentions": [],
"quotes": [],
"status": "silent"
},
"open": true,
"query_available": true,
"reasons": [],
"specificity_distinguished": "hypoglycaemia level 1, level 2, level 3 (E16.A1-E16.A3, new; not yet in the 2027 initial HCC file), drug-induced without coma, other, unspecified; in diabetes the combination codes E08-E13 with .64- are used",
"state": "met",
"supported": {
"category": "level_1",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-04",
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
}
]
},
"tier": "measured",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-04",
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
}
]
}
],
"config": "library_default_set@1.0",
"definitions": {
"ada2026_diabetes@1.0": "e6a402d238eabf948e24e0c1a768094b2a8eab1534d0208b533bcf624a7c56a7",
"ada2026_hypoglycaemia@1.0": "46bd77ec8ba977e0a1f201d4ef02d934accd0ab454ed12ef6d6c7f189f56a9a0",
"ada2026_prediabetes@1.0": "af2c23fe63c64897f2f72242153b81971f32dba4ad55ac279abf2a2991d0e112",
"aha2018_severe_hypercholesterolaemia@1.0": "07ac207b49ba33e7c341f45bd1e6652460273e35b8ccb6e9882ce4e14506f24b",
"atp3_ldl@1.0": "984f30f535df92c4f68bcb7331a079e98e17980f6cba9e3e3ca40f3dda5eee03",
"berlin2012_ards_pf@1.0": "f6d9be0dcd8cd4f86bcc8ecd1bd12854e408cc9e25db8f136564584b9c202d77",
"cdc_adult_bmi@1.0": "14a2ac45496eea318a30ab4841e1635efe3b8051355ff920c39b471475a3fa80",
"esc2024_office_bp@1.0": "f507c6c22d66beccef76705f376bfcd942d7852733727916e8e70c9b78ef9f4c",
"ese2014_hyponatraemia@1.0": "80cb82e9b02b3fc8c2af10544ac52733b115d2a2436f871ddd9f56276c4fd90b",
"global2024_ards_intubated_pf@1.0": "64bbc3f7fa5c4c0c445d87883b20d22351bdb59ba670062bb4807a1bc924b89f",
"gold2026_copd_airflow@1.0": "5fe646eb07866c220b55269655e680c559148e99cda65c6dd5faf3198d549e93",
"nhlbi_bp_categories@1.0": "17c10323497aaed97bf08b4f9db27dc328068eccd4fd0fccf11af416207b76d3",
"sepsis3_septic_shock_lactate@1.0": "349d2d1b41e02f6a8ad26bd1df917967ec1b78539948f165c14d29e427e8d6aa",
"uhf2021_hf_ef_category@1.0": "d056531cd58ff1c18dba497a2ed8f8373ed9f9583c3a072a8b525d6a67eb61c3",
"ukka2026_hyperkalaemia@1.0": "52e59d35a9e19548932d6bf551f322dbcd68e1e05aab0ba68e346d81eaf35c73",
"who1994_osteoporosis@1.0": "285f666b9d1cbe759d9b827772316840002f5b2439b71ed10aedcb437a089014",
"who2020_iron_deficiency_ferritin@1.0": "1cf50051fb66f445ab663519fb2ec6e5d60dc73f96a9ee96a86becd424e10ad1",
"who2024_anaemia@1.0": "f2ece42ed4d7349094e3066f58b4bd9aece49873b33aa458945093e29ad4cede",
"who_adult_bmi@1.0": "de4e41b72636521df138a3846f673cb8d1f1bb3695ace4d31b592352a719668e"
},
"engine": "library-engine 1.0",
"findings": [
{
"checks": [
"contradiction",
"not_stated"
],
"citation": {
"code_reference": {
"categories": [
{
"billable_codes_fy2027": 10,
"category": "E16",
"cms_hcc_v28": {
"codes_mapping": 0,
"hccs": []
},
"ms_drg_v44": {
"codes_with_cc": 0,
"codes_with_mcc": 0,
"summary": "no code in this category is on the FY2027 CC or MCC list"
},
"note": null,
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "hypoglycaemia level 1, level 2, level 3 (E16.A1-E16.A3, new; not yet in the 2027 initial HCC file), drug-induced without coma, other, unspecified; in diabetes the combination codes E08-E13 with .64- are used",
"title": "Other disorders of pancreatic internal secretion"
},
{
"billable_codes_fy2027": 87,
"category": "E11",
"cms_hcc_v28": {
"codes_mapping": 76,
"hccs": [
"36",
"37",
"38",
"263",
"298",
"383"
]
},
"ms_drg_v44": {
"codes_with_cc": 1,
"codes_with_mcc": 5,
"summary": "5 MCC and 1 CC codes"
},
"note": null,
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "type 2 diabetes with hypoglycaemia with or without coma (E11.64-)",
"title": "Type 2 diabetes mellitus"
}
],
"icd10cm_fiscal_year": "FY2027 (effective 2026-10-01)",
"null_reason": null,
"use": "reference for coders \u2014 the software never assigns or suggests a code"
},
"condition": "Hypoglycaemia",
"confirmation": null,
"contested": {
"is_contested": true,
"why": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs."
},
"edition": {
"checked_at": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690178/",
"checked_on": "2026-11-14",
"edition": "Standards of Care in Diabetes\u20142026",
"is_current": true,
"note": "Section 6 of the 2026 Standards is the newest indexed edition; read from the PubMed Central copy.",
"year": 2026
},
"id": "ada2026_hypoglycaemia",
"inputs": [
{
"analyte": "glucose_plasma",
"key": "glu",
"select": "lowest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
}
],
"interpretation_notes": [
"The lowest glucose among the measurements passed is classified.",
"ADA prints both units; each unit is compared against its own printed number (3.0 mmol/L is 54.05 mg/dL)."
],
"kind": "executable definition",
"not_encoded": [
"Level 3 is clinical: it is reported only when the caller supplies severe_event_requiring_assistance = true; otherwise it is skipped with a note.",
"Whether the glucose came from a meter, CGM or laboratory is not distinguished; CGM duration criteria (for example 15 minutes) are not stated in the opened table and are not encoded."
],
"population": "people with diabetes (section 6 of the Standards of Care in Diabetes)",
"primary_source": {
"accessed": "2026-11-14",
"body": "American Diabetes Association Professional Practice Committee",
"edition": "2026 (Diabetes Care 2026;49 Suppl 1)",
"locator": "Table 6.4 Classification of hypoglycemia",
"quote": "Level 1: Glucose <70 mg/dL (<3.9 mmol/L) and \u226554 mg/dL (\u22653.0 mmol/L). Level 2: Glucose <54 mg/dL (<3.0 mmol/L). Level 3: A severe event characterized by altered mental and/or physical status requiring assistance for treatment of hypoglycemia",
"title": "6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes\u20142026",
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690178/",
"year": 2026
},
"second_source": {
"accessed": "2026-11-14",
"body": "International Hypoglycaemia Study Group",
"edition": "2017 (Diabetologia 2017;60:3-6, doi:10.1007/s00125-016-4146-6)",
"locator": "Main text",
"quote": "a glucose concentration <3.0 mmol/l (<54 mg/dl) is sufficiently low to indicate serious, clinically important hypoglycaemia",
"title": "Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes",
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6518070/",
"year": 2017
},
"second_source_note": "Agrees on level 2 (<3.0 mmol/L, <54 mg/dL) and on level 3 being clinical; disagrees on level 1 at exactly 70 mg/dL ('3.9 mmol/l (70 mg/dl) or less').",
"second_source_status": "partly agrees",
"status": "draft \u2014 requires clinical and coding review",
"thresholds": [
{
"categories": [
{
"condition_present": true,
"id": "level_3",
"label": "Level 3: severe event requiring assistance (irrespective of glucose)",
"rule": "severe_event_requiring_assistance = True"
},
{
"condition_present": true,
"id": "level_2",
"label": "Level 2: glucose <54 mg/dL (<3.0 mmol/L)",
"rule": "glu < 54 mg/dL / 3 mmol/L"
},
{
"condition_present": true,
"id": "level_1",
"label": "Level 1: glucose <70 mg/dL (<3.9 mmol/L) and \u226554 mg/dL (\u22653.0 mmol/L)",
"rule": "glu \u2265 54 mg/dL / 3 mmol/L and glu < 70 mg/dL / 3.9 mmol/L"
},
{
"condition_present": false,
"id": "not_low",
"label": "Glucose 70 mg/dL (3.9 mmol/L) or above",
"rule": "glu \u2265 70 mg/dL / 3.9 mmol/L"
}
],
"variant": "all",
"variant_label": "all patients in the population"
}
],
"tier": 1,
"title": "Hypoglycaemia level (ADA Standards of Care 2026)",
"version": "1.0"
},
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"direction": "UNDER",
"draft": true,
"family": "hypoglycaemia",
"family_order": 5,
"id": "ada2026_hypoglycaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "level_1",
"category_label": "Level 1: glucose <70 mg/dL (<3.9 mmol/L) and \u226554 mg/dL (\u22653.0 mmol/L)",
"clinician_label": "level 1 (glucose 54 to below 70 mg/dL)",
"condition_threshold": "level 3 (severe event needing assistance) (a recorded clinical item); level 2 (glucose below 54 mg/dL) (glucose < 54 mg/dL); level 1 (glucose 54 to below 70 mg/dL) (glucose \u2265 54 mg/dL and glucose < 70 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"edition_current": true,
"family": "hypoglycaemia",
"has_data": true,
"id": "ada2026_hypoglycaemia",
"missing_context": [],
"notes": [
"'Level 3: severe event requiring assistance (irrespective of glucose)' could not be assessed and was skipped: context 'severe_event_requiring_assistance' not provided"
],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "not_low",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-11-11T10:00:00-05:00",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-03",
"time": "2026-11-11T10:00:00-05:00",
"unit": "mg/dL",
"value": 182.0
}
]
},
{
"category": "level_1",
"confirmed": true,
"result": "met",
"time": "2026-11-12T06:00:00-05:00",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-04",
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "level_1",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-04",
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
}
]
},
"threshold": "glucose \u2265 54 mg/dL and glucose < 70 mg/dL",
"tier": "measured",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-04",
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
2,
5,
"hypoglycaemia"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Low glucose values",
"version": "1.0",
"why": ""
},
{
"checks": [
"contradiction",
"specificity"
],
"citation": {
"code_reference": {
"categories": [
{
"billable_codes_fy2027": 87,
"category": "E11",
"cms_hcc_v28": {
"codes_mapping": 76,
"hccs": [
"36",
"37",
"38",
"263",
"298",
"383"
]
},
"ms_drg_v44": {
"codes_with_cc": 1,
"codes_with_mcc": 5,
"summary": "5 MCC and 1 CC codes"
},
"note": "Type of diabetes must be documented; E10 (type 1), E08/E09/E13 (other types) are parallel categories.",
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "type 2 diabetes with or without complications by body system (kidney, eye, nerve, circulatory, skin, oral, hypoglycaemia, hyperglycaemia, ketoacidosis, hyperosmolarity), long-term drug use is separate (Z79)",
"title": "Type 2 diabetes mellitus"
},
{
"billable_codes_fy2027": 87,
"category": "E10",
"cms_hcc_v28": {
"codes_mapping": 74,
"hccs": [
"36",
"37",
"38",
"263",
"298",
"383"
]
},
"ms_drg_v44": {
"codes_with_cc": 1,
"codes_with_mcc": 3,
"summary": "3 MCC and 1 CC codes"
},
"note": null,
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "type 1 diabetes with the same complication axes as E11",
"title": "Type 1 diabetes mellitus"
}
],
"icd10cm_fiscal_year": "FY2027 (effective 2026-10-01)",
"null_reason": null,
"use": "reference for coders \u2014 the software never assigns or suggests a code"
},
"condition": "Diabetes mellitus",
"confirmation": null,
"contested": {
"is_contested": false,
"why": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text)."
},
"edition": {
"checked_at": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/",
"checked_on": "2026-11-14",
"edition": "Standards of Care in Diabetes\u20142026",
"is_current": true,
"note": "The 2026 Standards (Diabetes Care 2026;49 Suppl 1) are the newest edition indexed (Europe PMC lists 2024, 2025 and 2026 versions of section 2). The publisher site refused automated access (HTTP 403); the PubMed Central copy was read.",
"year": 2026
},
"id": "ada2026_diabetes",
"inputs": [
{
"analyte": "hba1c",
"key": "a1c",
"select": "latest",
"source_units": [
"%",
"mmol/mol"
],
"unit": "%"
},
{
"analyte": "glucose_fasting_plasma",
"key": "fpg",
"select": "latest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
},
{
"analyte": "glucose_ogtt_2h_plasma",
"key": "ogtt",
"select": "latest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
},
{
"analyte": "glucose_random_plasma",
"key": "rpg",
"select": "highest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
}
],
"interpretation_notes": [
"Each A1C, fasting glucose and 2-h OGTT measurement at or above its threshold counts as one abnormal result; two results at the same time from different tests count as two (ADA: 'may be obtained at the same time (e.g., A1C and FPG)'); the same test twice counts only at two different times (records with identical analyte and time are one record).",
"A random glucose \u2265200 mg/dL counts only with classic symptoms or crisis and is not counted towards the two-result rule.",
"ADA prints both units for each threshold; each unit is compared against its own printed number (48 mmol/mol, 7.0 mmol/L, 11.1 mmol/L)."
],
"kind": "executable definition",
"not_encoded": [
"Type of diabetes (type 1, type 2, other) is not assessed.",
"Conditions that make A1C unreliable (some haemoglobin variants, pregnancy, G6PD deficiency, HIV, anaemia, haemodialysis, erythropoietin; recommendation 2.4 and text) are not checked: A1C results are used as sent.",
"No maximum interval between the two abnormal results is stated by the source and none is applied.",
"Whether the test method is NGSP-certified and whether a fasting sample was truly fasting are asserted by the sender through the analyte name.",
"When two different tests are discordant ADA advises repeating the abnormal test; this entry simply reports one abnormal result."
],
"population": "non-pregnant individuals (Table 2.1 title: 'in nonpregnant individuals')",
"primary_source": {
"accessed": "2026-11-14",
"body": "American Diabetes Association Professional Practice Committee",
"edition": "2026 (Diabetes Care 2026;49 Suppl 1:S27-S49, doi:10.2337/dc26-S002)",
"locator": "Table 2.1 Criteria for the diagnosis of diabetes in nonpregnant individuals",
"quote": "Table 2.1: A1C \u22656.5% (\u226548 mmol/mol); FPG \u2265126 mg/dL (\u22657.0 mmol/L); 2-h PG \u2265200 mg/dL (\u226511.1 mmol/L) during OGTT; random plasma glucose \u2265200 mg/dL (\u226511.1 mmol/L) with classic symptoms of hyperglycemia or hyperglycemic crisis. In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal results from different tests ... or the same test at two different time points.",
"title": "2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026",
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/",
"year": 2026
},
"second_source": null,
"second_source_note": "The WHO diabetes fact sheet (dated 11 November 2026) states no numeric thresholds; the WHO 2006/2011 reports were not opened. No independent second source was opened.",
"second_source_status": "not found",
"status": "draft \u2014 requires clinical and coding review",
"thresholds": [
{
"categories": [
{
"condition_present": true,
"id": "confirmed",
"label": "Diabetes criteria met: two abnormal results (different tests, or the same test at two times)",
"rule": "number of results meeting [a1c \u2265 6.5 % / 48 mmol/mol; fpg \u2265 126 mg/dL / 7 mmol/L; ogtt \u2265 200 mg/dL / 11.1 mmol/L] \u2265 2"
},
{
"condition_present": true,
"id": "random_with_symptoms",
"label": "Diabetes criteria met: random plasma glucose \u2265200 mg/dL with classic symptoms or crisis",
"rule": "rpg \u2265 200 mg/dL / 11.1 mmol/L and classic_symptoms_or_crisis = True"
},
{
"condition_present": true,
"id": "single_abnormal",
"label": "One abnormal result \u2014 ADA requires a second abnormal result to confirm",
"rule": "number of results meeting [a1c \u2265 6.5 % / 48 mmol/mol; fpg \u2265 126 mg/dL / 7 mmol/L; ogtt \u2265 200 mg/dL / 11.1 mmol/L] \u2265 1"
}
],
"variant": "all",
"variant_label": "all patients in the population"
}
],
"tier": 1,
"title": "Diabetes diagnostic thresholds and the confirmation rule (ADA Standards of Care 2026)",
"version": "1.0"
},
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"direction": "CONSISTENT",
"draft": true,
"family": "diabetes",
"family_order": 3,
"id": "ada2026_diabetes",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "confirmed",
"category_label": "Diabetes criteria met: two abnormal results (different tests, or the same test at two times)",
"clinician_label": "two results at or above the diagnostic thresholds",
"condition_threshold": "two results at or above the diagnostic thresholds (number of qualifying results \u2265 2); random glucose 200 mg/dL or more with typical symptoms (random glucose \u2265 200 mg/dL and a recorded clinical item); one result at or above a diagnostic threshold (number of qualifying results \u2265 1)",
"confirmation": null,
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"edition_current": true,
"family": "diabetes",
"has_data": true,
"id": "ada2026_diabetes",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "single_abnormal",
"confirmed": false,
"result": "met",
"time": "2026-04-25T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-01",
"time": "2026-04-25T09:00:00-04:00",
"unit": "%",
"value": 8.0
}
]
},
{
"category": "confirmed",
"confirmed": true,
"result": "met",
"time": "2026-09-12T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "confirmed",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
},
"threshold": "number of qualifying results \u2265 2",
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"note": {
"faults": [],
"spans": [
{
"assertion": "affirmed",
"categories": [],
"end": 265,
"family": "diabetes",
"general": true,
"origin": "both",
"quote": "diabetes",
"start": 257,
"words": [
"type 2"
]
}
],
"status": "stated"
},
"optional_set": null,
"priority": [
6,
3,
"diabetes"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Glucose and HbA1c",
"version": "1.0",
"why": ""
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": {
"code_reference": {
"categories": [
{
"billable_codes_fy2027": 14,
"category": "E87",
"cms_hcc_v28": {
"codes_mapping": 0,
"hccs": []
},
"ms_drg_v44": {
"codes_with_cc": 8,
"codes_with_mcc": 0,
"summary": "some codes in this category are CC"
},
"note": null,
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "E87.5 hyperkalemia (one code; no severity axis)",
"title": "Other disorders of fluid, electrolyte and acid-base balance"
}
],
"icd10cm_fiscal_year": "FY2027 (effective 2026-10-01)",
"null_reason": null,
"use": "reference for coders \u2014 the software never assigns or suggests a code"
},
"condition": "Hyperkalaemia",
"confirmation": null,
"contested": {
"is_contested": true,
"why": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia)."
},
"edition": {
"checked_at": "https://www.ukkidney.org/sites/default/files/documents/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20UPDATED%20JULY%202026_0.pdf",
"checked_on": "2026-11-14",
"edition": "updated July 2026",
"is_current": true,
"note": "Document front page: original July 2020, updated October 2023, updated July 2026, review date October 2026. The July 2026 file is the newest found on the association's site.",
"year": 2026
},
"id": "ukka2026_hyperkalaemia",
"inputs": [
{
"analyte": "potassium_serum",
"key": "k",
"select": "latest",
"source_units": [
"mmol/L"
],
"unit": "mmol/L"
}
],
"interpretation_notes": [
"Adjacent printed ranges that differ by one reporting unit (for example '120\u2013129' then '130\u2013139', or '5.5-5.9' then '6.0-6.4') are read as half-open intervals [lower, next lower), so a value between them (129.5, 5.95) falls in the lower band. Only a genuine gap in the printed ranges returns not assessable.",
"The introduction once writes 'severe hyperkalaemia (K+ > 6.5 mmol/l)' but the classification sentence and every guideline statement use '\u2265 6.5'; \u22656.5 is encoded.",
"The most recent potassium up to as_of is used."
],
"kind": "executable definition",
"not_encoded": [
"Pseudohyperkalaemia (guideline 15.3: haemolysis, delayed analysis, sampling technique) is not detected; a haemolysed sample is graded like any other unless the sender withholds it.",
"Acute versus chronic (persistent) hyperkalaemia and the guideline's repeat-testing intervals (guidelines 1.2.1-1.2.3) are not encoded.",
"ECG changes and clinical context are not assessed."
],
"population": "adults (the guideline title: 'in Adults')",
"primary_source": {
"accessed": "2026-11-14",
"body": "UK Kidney Association",
"edition": "updated July 2026",
"locator": "Introduction, document page 9 (PDF page 10)",
"quote": "It is further classified by severity into mild (5.5-5.9 mmol/l), moderate (6.0-6.4 mmol/l) or severe (\u2265 6.5 mmol/l).",
"title": "Clinical Practice Guidelines: Treatment of Acute Hyperkalaemia in Adults",
"url": "https://www.ukkidney.org/sites/default/files/documents/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20UPDATED%20JULY%202026_0.pdf",
"year": 2026
},
"second_source": {
"accessed": "2026-11-14",
"body": "National Cancer Institute, Cancer Therapy Evaluation Program (U.S. Department of Health and Human Services)",
"edition": "v6.0",
"locator": "PDF page 177, term 'Hyperkalemia' (published July 22, 2025)",
"quote": "Grade 1: >ULN - 5.5 mmol/L. Grade 2: >5.5 - 6.0 mmol/L ... Grade 4: >7.0 mmol/L",
"title": "Common Terminology Criteria for Adverse Events (CTCAE) v6.0 (MedDRA 28.0)",
"url": "https://dctd.cancer.gov/research/ctep-trials/for-sites/adverse-events/ctcae-v6.pdf",
"year": 2025
},
"second_source_note": "CTCAE uses different bands; the UKKA text states its 5.5 mmol/L threshold comes from the European Resuscitation Council guideline, which was not opened.",
"second_source_status": "disagrees",
"status": "draft \u2014 requires clinical and coding review",
"thresholds": [
{
"categories": [
{
"condition_present": true,
"id": "severe",
"label": "Severe hyperkalaemia (\u22656.5 mmol/L)",
"rule": "k \u2265 6.5 mmol/L"
},
{
"condition_present": true,
"id": "moderate",
"label": "Moderate hyperkalaemia (6.0\u20136.4 mmol/L)",
"rule": "k \u2265 6 mmol/L and k < 6.5 mmol/L"
},
{
"condition_present": true,
"id": "mild",
"label": "Mild hyperkalaemia (5.5\u20135.9 mmol/L)",
"rule": "k \u2265 5.5 mmol/L and k < 6 mmol/L"
},
{
"condition_present": false,
"id": "below_threshold",
"label": "Below 5.5 mmol/L",
"rule": "k < 5.5 mmol/L"
}
],
"variant": "all",
"variant_label": "all patients in the population"
}
],
"tier": 1,
"title": "Hyperkalaemia and its severity (UK Kidney Association, July 2026 update)",
"version": "1.0"
},
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"direction": "NONE",
"draft": true,
"family": "potassium",
"family_order": 2,
"id": "ukka2026_hyperkalaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "below_threshold",
"category_label": "Below 5.5 mmol/L",
"clinician_label": "below 5.5 mmol/L",
"condition_threshold": "'severe' band (6.5 mmol/L or more) (potassium \u2265 6.5 mmol/L); 'moderate' band (6.0 to 6.4 mmol/L) (potassium \u2265 6 mmol/L and potassium < 6.5 mmol/L); 'mild' band (5.5 to 5.9 mmol/L) (potassium \u2265 5.5 mmol/L and potassium < 6 mmol/L)",
"confirmation": null,
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"edition_current": true,
"family": "potassium",
"has_data": true,
"id": "ukka2026_hyperkalaemia",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "criteria_not_met",
"scan": [
{
"category": "below_threshold",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-11-12T07:00:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P16-05",
"time": "2026-11-12T07:00:00-05:00",
"unit": "mmol/L",
"value": 5.3
}
]
}
],
"state": "not_met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": "potassium < 5.5 mmol/L",
"tier": "measured",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P16-05",
"time": "2026-11-12T07:00:00-05:00",
"unit": "mmol/L",
"value": 5.3
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 1,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
7,
2,
"potassium"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Potassium",
"version": "1.0",
"why": ""
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": {
"code_reference": {
"categories": [
{
"billable_codes_fy2027": 5,
"category": "R73",
"cms_hcc_v28": {
"codes_mapping": 0,
"hccs": []
},
"ms_drg_v44": {
"codes_with_cc": 0,
"codes_with_mcc": 0,
"summary": "no code in this category is on the FY2027 CC or MCC list"
},
"note": null,
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "R73.01 impaired fasting glucose, R73.02 impaired glucose tolerance (oral), R73.03 prediabetes, R73.09 other abnormal glucose, R73.9 hyperglycaemia unspecified",
"title": "Elevated blood glucose level"
}
],
"icd10cm_fiscal_year": "FY2027 (effective 2026-10-01)",
"null_reason": null,
"use": "reference for coders \u2014 the software never assigns or suggests a code"
},
"condition": "Prediabetes",
"confirmation": null,
"contested": {
"is_contested": true,
"why": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item."
},
"edition": {
"checked_at": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/",
"checked_on": "2026-11-14",
"edition": "Standards of Care in Diabetes\u20142026",
"is_current": true,
"note": "The 2026 Standards (Diabetes Care 2026;49 Suppl 1) are the newest edition indexed (Europe PMC lists 2024, 2025 and 2026 versions of section 2). The publisher site refused automated access (HTTP 403); the PubMed Central copy was read.",
"year": 2026
},
"id": "ada2026_prediabetes",
"inputs": [
{
"analyte": "hba1c",
"key": "a1c",
"select": "latest",
"source_units": [
"%",
"mmol/mol"
],
"unit": "%"
},
{
"analyte": "glucose_fasting_plasma",
"key": "fpg",
"select": "latest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
},
{
"analyte": "glucose_ogtt_2h_plasma",
"key": "ogtt",
"select": "latest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
}
],
"interpretation_notes": [
"Adjacent printed ranges that differ by one reporting unit (for example '120\u2013129' then '130\u2013139', or '5.5-5.9' then '6.0-6.4') are read as half-open intervals [lower, next lower), so a value between them (129.5, 5.95) falls in the lower band. Only a genuine gap in the printed ranges returns not assessable. A1C '5.7\u20136.4%' is read as [5.7, 6.5) since 6.5% starts the diabetes range; '39\u201347 mmol/mol' as [39, 48); FPG '100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L)' as [100, 126) mg/dL and [5.6, 7.0) mmol/L; 2-h PG '140 (7.8) to 199 (11.0)' as [140, 200) mg/dL and [7.8, 11.1) mmol/L.",
"If any most-recent result is in the diabetes range the entry reports that and does not assign prediabetes."
],
"kind": "executable definition",
"not_encoded": [
"ADA does not require confirmation for prediabetes in Table 2.2; none is applied.",
"A1C reliability conditions are not checked (see ada2026_diabetes).",
"Only the most recent result of each test is used."
],
"population": "non-pregnant individuals (Table 2.2 title)",
"primary_source": {
"accessed": "2026-11-14",
"body": "American Diabetes Association Professional Practice Committee",
"edition": "2026 (Diabetes Care 2026;49 Suppl 1:S27-S49)",
"locator": "Table 2.2 Criteria defining prediabetes in nonpregnant individuals",
"quote": "A1C 5.7\u20136.4% (39\u201347 mmol/mol); FPG 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (IFG); 2-h PG during 75-g OGTT 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) (IGT)",
"title": "2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026",
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/",
"year": 2026
},
"second_source": null,
"second_source_note": "No independent second source was opened.",
"second_source_status": "not found",
"status": "draft \u2014 requires clinical and coding review",
"thresholds": [
{
"categories": [
{
"condition_present": false,
"id": "diabetes_range",
"label": "A result is in the diabetes range \u2014 prediabetes not assigned; see ada2026_diabetes",
"rule": "a1c \u2265 6.5 % / 48 mmol/mol or fpg \u2265 126 mg/dL / 7 mmol/L or ogtt \u2265 200 mg/dL / 11.1 mmol/L"
},
{
"condition_present": true,
"id": "prediabetes",
"label": "Prediabetes range (A1C 5.7\u20136.4%, IFG 100\u2013125 mg/dL or IGT 140\u2013199 mg/dL)",
"rule": "a1c \u2265 5.7 % / 39 mmol/mol and a1c < 6.5 % / 48 mmol/mol or fpg \u2265 100 mg/dL / 5.6 mmol/L and fpg < 126 mg/dL / 7 mmol/L or ogtt \u2265 140 mg/dL / 7.8 mmol/L and ogtt < 200 mg/dL / 11.1 mmol/L"
}
],
"variant": "all",
"variant_label": "all patients in the population"
}
],
"tier": 1,
"title": "Prediabetes ranges (ADA Standards of Care 2026)",
"version": "1.0"
},
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"direction": "NONE",
"draft": true,
"family": "prediabetes",
"family_order": 4,
"id": "ada2026_prediabetes",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "diabetes_range",
"category_label": "A result is in the diabetes range \u2014 prediabetes not assigned; see ada2026_diabetes",
"clinician_label": "a result in the higher (diagnostic) range",
"condition_threshold": "intermediate range (HbA1c 5.7 to 6.4%, fasting glucose 100 to 125 mg/dL, or 2-hour glucose 140 to 199 mg/dL) (HbA1c \u2265 5.7 % and HbA1c < 6.5 % or fasting glucose \u2265 100 mg/dL and fasting glucose < 126 mg/dL or 2-hour glucose \u2265 140 mg/dL and 2-hour glucose < 200 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"edition_current": true,
"family": "prediabetes",
"has_data": true,
"id": "ada2026_prediabetes",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "criteria_not_met",
"scan": [
{
"category": "diabetes_range",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-04-25T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-01",
"time": "2026-04-25T09:00:00-04:00",
"unit": "%",
"value": 8.0
}
]
},
{
"category": "diabetes_range",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-09-12T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
}
],
"state": "not_met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": "HbA1c \u2265 6.5 % or fasting glucose \u2265 126 mg/dL or 2-hour glucose \u2265 200 mg/dL",
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
7,
4,
"prediabetes"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Glucose and HbA1c (intermediate range)",
"version": "1.0",
"why": ""
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "haemoglobin",
"family_order": 0,
"id": "who2024_anaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "'severe' band (haemoglobin < 70 g/L); 'moderate' band (haemoglobin \u2265 70 g/L and haemoglobin < 100 g/L); 'mild' band (haemoglobin \u2265 100 g/L and haemoglobin < 110 g/L)",
"confirmation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"edition_current": true,
"family": "haemoglobin",
"has_data": false,
"id": "who2024_anaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"outside the population the source defines: individuals aged 6 months to 65 years (Table 2 covers no other ages); pregnancy by trimester"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 30,
"from": "2026-10-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
0,
"haemoglobin"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Haemoglobin",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "sodium",
"family_order": 1,
"id": "ese2014_hyponatraemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "below 135 mmol/L (sodium < 135 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"edition_current": null,
"family": "sodium",
"has_data": false,
"id": "ese2014_hyponatraemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable sodium_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
1,
"sodium"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Sodium",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "bmi",
"family_order": 6,
"id": "cdc_adult_bmi",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "who_adult_bmi@1.0",
"id": "who_adult_bmi",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "40 or more band (class 3) (body-mass index \u2265 40 kg/m2); 35 to below 40 band (class 2) (body-mass index \u2265 35 kg/m2 and body-mass index < 40 kg/m2); 30 to below 35 band (class 1) (body-mass index \u2265 30 kg/m2 and body-mass index < 35 kg/m2); 25 to below 30 band (body-mass index \u2265 25 kg/m2 and body-mass index < 30 kg/m2); below 18.5 band (body-mass index < 18.5 kg/m2)",
"confirmation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"edition_current": true,
"family": "bmi",
"has_data": false,
"id": "cdc_adult_bmi",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
6,
"bmi"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Body-mass index",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "blood_pressure",
"family_order": 7,
"id": "nhlbi_bp_categories",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "esc2024_office_bp@1.0",
"id": "esc2024_office_bp",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "range above 180 systolic or above 120 diastolic (systolic > 180 mmHg or diastolic > 120 mmHg); stage 2 range (140 or more systolic, or 90 or more diastolic) (systolic \u2265 140 mmHg or diastolic \u2265 90 mmHg); stage 1 range (130 to 139 systolic, or 80 to 89 diastolic) (systolic \u2265 130 mmHg and systolic < 140 mmHg or diastolic \u2265 80 mmHg and diastolic < 90 mmHg); elevated range (120 to 129 systolic and below 80 diastolic) (systolic \u2265 120 mmHg and systolic < 130 mmHg and diastolic < 80 mmHg)",
"confirmation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"edition_current": true,
"family": "blood_pressure",
"has_data": false,
"id": "nhlbi_bp_categories",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
7,
"blood_pressure"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Blood pressure readings",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "ldl",
"family_order": 8,
"id": "aha2018_severe_hypercholesterolaemia",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "atp3_ldl@1.0",
"id": "atp3_ldl",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "LDL 190 mg/dL or more (LDL \u2265 190 mg/dL)",
"confirmation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"edition_current": true,
"family": "ldl",
"has_data": false,
"id": "aha2018_severe_hypercholesterolaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
8,
"ldl"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "LDL cholesterol",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "ferritin",
"family_order": 9,
"id": "who2020_iron_deficiency_ferritin",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "band below the ferritin cut-off for this group (ferritin < 15 ug/L)",
"confirmation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"edition_current": true,
"family": "ferritin",
"has_data": false,
"id": "who2020_iron_deficiency_ferritin",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ferritin_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 180,
"from": "2026-05-17T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
9,
"ferritin"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Ferritin",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "bone_density",
"family_order": 10,
"id": "who1994_osteoporosis",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "T-score below -2.5 with a fragility fracture (T-score < -2.5 SD and a recorded clinical item); T-score -2.5 or lower band (T-score \u2264 -2.5 SD); T-score between -1 and -2.5 band (T-score > -2.5 SD and T-score < -1 SD)",
"confirmation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"edition_current": null,
"family": "bone_density",
"has_data": false,
"id": "who1994_osteoporosis",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"outside the population the source defines: postmenopausal women (the report's categories are stated 'in women' in the context of postmenopausal osteoporosis)"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
10,
"bone_density"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Bone density T-score",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "copd_airflow",
"family_order": 11,
"id": "gold2026_copd_airflow",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "FEV1/FVC below 0.7 with FEV1 below 30% predicted (grade 4) (FEV1/FVC < 0.7 and FEV1 % predicted < 30 %); FEV1/FVC below 0.7 with FEV1 30 to below 50% predicted (grade 3) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 30 % and FEV1 % predicted < 50 %); FEV1/FVC below 0.7 with FEV1 50 to below 80% predicted (grade 2) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 50 % and FEV1 % predicted < 80 %); FEV1/FVC below 0.7 with FEV1 80% predicted or more (grade 1) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 80 %)",
"confirmation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"edition_current": true,
"family": "copd_airflow",
"has_data": false,
"id": "gold2026_copd_airflow",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of fev1_fvc_ratio_post_bd, fev1_pct_predicted_post_bd recorded at the same time",
"no usable fev1_fvc_ratio_post_bd measurement",
"no usable fev1_pct_predicted_post_bd measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
11,
"copd_airflow"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Lung function after bronchodilator",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "heart_failure_ef",
"family_order": 12,
"id": "uhf2021_hf_ef_category",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "improved category (from 40% or below to above 40%, a rise of 10 points or more) (earliest ejection fraction \u2264 40 % and ejection fraction > 40 % and change in ejection fraction \u2265 10); 40% or below (ejection fraction \u2264 40 %); 41 to 49% (ejection fraction > 40 % and ejection fraction < 50 %); 50% or above (ejection fraction \u2265 50 %)",
"confirmation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"edition_current": null,
"family": "heart_failure_ef",
"has_data": false,
"id": "uhf2021_hf_ef_category",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'heart_failure' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
12,
"heart_failure_ef"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Ejection fraction",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "lactate",
"family_order": 13,
"id": "sepsis3_septic_shock_lactate",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "lactate above 2 mmol/L (lactate > 2 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"edition_current": true,
"family": "lactate",
"has_data": false,
"id": "sepsis3_septic_shock_lactate",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable lactate_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
13,
"lactate"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Lactate",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "oxygenation",
"family_order": 14,
"id": "global2024_ards_intubated_pf",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "berlin2012_ards_pf@1.0",
"id": "berlin2012_ards_pf",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of pao2, fio2 recorded at the same time",
"no usable fio2 measurement",
"no usable pao2 measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "PaO2/FiO2 \u2264 100; PaO2/FiO2 > 100 and PaO2/FiO2 \u2264 200; PaO2/FiO2 > 200 and PaO2/FiO2 \u2264 300",
"confirmation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"edition_current": true,
"family": "oxygenation",
"has_data": false,
"id": "global2024_ards_intubated_pf",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'intubated' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
14,
"oxygenation"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Oxygenation (PaO2/FiO2)",
"version": "1.0",
"why": ""
}
],
"measurement": {
"config": "library_default_set@1.0",
"context_used": {
"age_years": 73,
"has_diabetes": true,
"sex": "male"
},
"engine": "library-engine 1.0",
"families": {
"blood_pressure": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "esc2024_office_bp@1.0",
"id": "esc2024_office_bp",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "range above 180 systolic or above 120 diastolic (systolic > 180 mmHg or diastolic > 120 mmHg); stage 2 range (140 or more systolic, or 90 or more diastolic) (systolic \u2265 140 mmHg or diastolic \u2265 90 mmHg); stage 1 range (130 to 139 systolic, or 80 to 89 diastolic) (systolic \u2265 130 mmHg and systolic < 140 mmHg or diastolic \u2265 80 mmHg and diastolic < 90 mmHg); elevated range (120 to 129 systolic and below 80 diastolic) (systolic \u2265 120 mmHg and systolic < 130 mmHg and diastolic < 80 mmHg)",
"confirmation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"edition_current": true,
"family": "blood_pressure",
"has_data": false,
"id": "nhlbi_bp_categories",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"bmi": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "who_adult_bmi@1.0",
"id": "who_adult_bmi",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "40 or more band (class 3) (body-mass index \u2265 40 kg/m2); 35 to below 40 band (class 2) (body-mass index \u2265 35 kg/m2 and body-mass index < 40 kg/m2); 30 to below 35 band (class 1) (body-mass index \u2265 30 kg/m2 and body-mass index < 35 kg/m2); 25 to below 30 band (body-mass index \u2265 25 kg/m2 and body-mass index < 30 kg/m2); below 18.5 band (body-mass index < 18.5 kg/m2)",
"confirmation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"edition_current": true,
"family": "bmi",
"has_data": false,
"id": "cdc_adult_bmi",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"bone_density": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "T-score below -2.5 with a fragility fracture (T-score < -2.5 SD and a recorded clinical item); T-score -2.5 or lower band (T-score \u2264 -2.5 SD); T-score between -1 and -2.5 band (T-score > -2.5 SD and T-score < -1 SD)",
"confirmation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"edition_current": null,
"family": "bone_density",
"has_data": false,
"id": "who1994_osteoporosis",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"outside the population the source defines: postmenopausal women (the report's categories are stated 'in women' in the context of postmenopausal osteoporosis)"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"copd_airflow": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "FEV1/FVC below 0.7 with FEV1 below 30% predicted (grade 4) (FEV1/FVC < 0.7 and FEV1 % predicted < 30 %); FEV1/FVC below 0.7 with FEV1 30 to below 50% predicted (grade 3) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 30 % and FEV1 % predicted < 50 %); FEV1/FVC below 0.7 with FEV1 50 to below 80% predicted (grade 2) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 50 % and FEV1 % predicted < 80 %); FEV1/FVC below 0.7 with FEV1 80% predicted or more (grade 1) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 80 %)",
"confirmation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"edition_current": true,
"family": "copd_airflow",
"has_data": false,
"id": "gold2026_copd_airflow",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of fev1_fvc_ratio_post_bd, fev1_pct_predicted_post_bd recorded at the same time",
"no usable fev1_fvc_ratio_post_bd measurement",
"no usable fev1_pct_predicted_post_bd measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"diabetes": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "confirmed",
"category_label": "Diabetes criteria met: two abnormal results (different tests, or the same test at two times)",
"clinician_label": "two results at or above the diagnostic thresholds",
"condition_threshold": "two results at or above the diagnostic thresholds (number of qualifying results \u2265 2); random glucose 200 mg/dL or more with typical symptoms (random glucose \u2265 200 mg/dL and a recorded clinical item); one result at or above a diagnostic threshold (number of qualifying results \u2265 1)",
"confirmation": null,
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"edition_current": true,
"family": "diabetes",
"has_data": true,
"id": "ada2026_diabetes",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "single_abnormal",
"confirmed": false,
"result": "met",
"time": "2026-04-25T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-01",
"time": "2026-04-25T09:00:00-04:00",
"unit": "%",
"value": 8.0
}
]
},
{
"category": "confirmed",
"confirmed": true,
"result": "met",
"time": "2026-09-12T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "confirmed",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
},
"threshold": "number of qualifying results \u2265 2",
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"ferritin": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "band below the ferritin cut-off for this group (ferritin < 15 ug/L)",
"confirmation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"edition_current": true,
"family": "ferritin",
"has_data": false,
"id": "who2020_iron_deficiency_ferritin",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ferritin_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 180,
"from": "2026-05-17T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"haemoglobin": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "'severe' band (haemoglobin < 70 g/L); 'moderate' band (haemoglobin \u2265 70 g/L and haemoglobin < 100 g/L); 'mild' band (haemoglobin \u2265 100 g/L and haemoglobin < 110 g/L)",
"confirmation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"edition_current": true,
"family": "haemoglobin",
"has_data": false,
"id": "who2024_anaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"outside the population the source defines: individuals aged 6 months to 65 years (Table 2 covers no other ages); pregnancy by trimester"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 30,
"from": "2026-10-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"heart_failure_ef": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "improved category (from 40% or below to above 40%, a rise of 10 points or more) (earliest ejection fraction \u2264 40 % and ejection fraction > 40 % and change in ejection fraction \u2265 10); 40% or below (ejection fraction \u2264 40 %); 41 to 49% (ejection fraction > 40 % and ejection fraction < 50 %); 50% or above (ejection fraction \u2265 50 %)",
"confirmation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"edition_current": null,
"family": "heart_failure_ef",
"has_data": false,
"id": "uhf2021_hf_ef_category",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'heart_failure' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"hypoglycaemia": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "level_1",
"category_label": "Level 1: glucose <70 mg/dL (<3.9 mmol/L) and \u226554 mg/dL (\u22653.0 mmol/L)",
"clinician_label": "level 1 (glucose 54 to below 70 mg/dL)",
"condition_threshold": "level 3 (severe event needing assistance) (a recorded clinical item); level 2 (glucose below 54 mg/dL) (glucose < 54 mg/dL); level 1 (glucose 54 to below 70 mg/dL) (glucose \u2265 54 mg/dL and glucose < 70 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"edition_current": true,
"family": "hypoglycaemia",
"has_data": true,
"id": "ada2026_hypoglycaemia",
"missing_context": [],
"notes": [
"'Level 3: severe event requiring assistance (irrespective of glucose)' could not be assessed and was skipped: context 'severe_event_requiring_assistance' not provided"
],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "not_low",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-11-11T10:00:00-05:00",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-03",
"time": "2026-11-11T10:00:00-05:00",
"unit": "mg/dL",
"value": 182.0
}
]
},
{
"category": "level_1",
"confirmed": true,
"result": "met",
"time": "2026-11-12T06:00:00-05:00",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-04",
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "level_1",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-04",
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
}
]
},
"threshold": "glucose \u2265 54 mg/dL and glucose < 70 mg/dL",
"tier": "measured",
"values": [
{
"analyte": "glucose_plasma",
"measurement_id": "LM-P16-04",
"time": "2026-11-12T06:00:00-05:00",
"unit": "mg/dL",
"value": 62.0
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"lactate": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "lactate above 2 mmol/L (lactate > 2 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"edition_current": true,
"family": "lactate",
"has_data": false,
"id": "sepsis3_septic_shock_lactate",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable lactate_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"ldl": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "atp3_ldl@1.0",
"id": "atp3_ldl",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "LDL 190 mg/dL or more (LDL \u2265 190 mg/dL)",
"confirmation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"edition_current": true,
"family": "ldl",
"has_data": false,
"id": "aha2018_severe_hypercholesterolaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"oxygenation": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "berlin2012_ards_pf@1.0",
"id": "berlin2012_ards_pf",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of pao2, fio2 recorded at the same time",
"no usable fio2 measurement",
"no usable pao2 measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "PaO2/FiO2 \u2264 100; PaO2/FiO2 > 100 and PaO2/FiO2 \u2264 200; PaO2/FiO2 > 200 and PaO2/FiO2 \u2264 300",
"confirmation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"edition_current": true,
"family": "oxygenation",
"has_data": false,
"id": "global2024_ards_intubated_pf",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'intubated' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"potassium": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "below_threshold",
"category_label": "Below 5.5 mmol/L",
"clinician_label": "below 5.5 mmol/L",
"condition_threshold": "'severe' band (6.5 mmol/L or more) (potassium \u2265 6.5 mmol/L); 'moderate' band (6.0 to 6.4 mmol/L) (potassium \u2265 6 mmol/L and potassium < 6.5 mmol/L); 'mild' band (5.5 to 5.9 mmol/L) (potassium \u2265 5.5 mmol/L and potassium < 6 mmol/L)",
"confirmation": null,
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"edition_current": true,
"family": "potassium",
"has_data": true,
"id": "ukka2026_hyperkalaemia",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "criteria_not_met",
"scan": [
{
"category": "below_threshold",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-11-12T07:00:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P16-05",
"time": "2026-11-12T07:00:00-05:00",
"unit": "mmol/L",
"value": 5.3
}
]
}
],
"state": "not_met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": "potassium < 5.5 mmol/L",
"tier": "measured",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P16-05",
"time": "2026-11-12T07:00:00-05:00",
"unit": "mmol/L",
"value": 5.3
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 1,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": false
},
"prediabetes": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "diabetes_range",
"category_label": "A result is in the diabetes range \u2014 prediabetes not assigned; see ada2026_diabetes",
"clinician_label": "a result in the higher (diagnostic) range",
"condition_threshold": "intermediate range (HbA1c 5.7 to 6.4%, fasting glucose 100 to 125 mg/dL, or 2-hour glucose 140 to 199 mg/dL) (HbA1c \u2265 5.7 % and HbA1c < 6.5 % or fasting glucose \u2265 100 mg/dL and fasting glucose < 126 mg/dL or 2-hour glucose \u2265 140 mg/dL and 2-hour glucose < 200 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"edition_current": true,
"family": "prediabetes",
"has_data": true,
"id": "ada2026_prediabetes",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "criteria_not_met",
"scan": [
{
"category": "diabetes_range",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-04-25T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-01",
"time": "2026-04-25T09:00:00-04:00",
"unit": "%",
"value": 8.0
}
]
},
{
"category": "diabetes_range",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-09-12T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
]
}
],
"state": "not_met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": "HbA1c \u2265 6.5 % or fasting glucose \u2265 126 mg/dL or 2-hour glucose \u2265 200 mg/dL",
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P16-02",
"time": "2026-09-12T09:00:00-04:00",
"unit": "%",
"value": 8.2
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": false
},
"sodium": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "below 135 mmol/L (sodium < 135 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"edition_current": null,
"family": "sodium",
"has_data": false,
"id": "ese2014_hyponatraemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable sodium_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
}
}
},
"measurement_sha256": "c3a341a601b1e801f185758cefe14e94cbcea1ab1a850f5645e048c69d16ba6e",
"reader": {
"lexicon": "library-lexicon 1.0",
"model_status": "ok",
"reader": "lexicon+model"
}
}